APA (7th ed.) Citation

JS, C., AJ, H., M, K., WM, H., AM, F., EB, B., & BS, T. (2026). Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial. Cancers, 18(3), . https://doi.org/10.3390/cancers18030352

Chicago Style (17th ed.) Citation

JS, Cummock, Haider AJ, Kazmi M, Haque WM, Farach AM, Butler EB, and Teh BS. "Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial." Cancers 18, no. 3 (2026). https://doi.org/10.3390/cancers18030352.

MLA (9th ed.) Citation

JS, Cummock, et al. "Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial." Cancers, vol. 18, no. 3, 2026, https://doi.org/10.3390/cancers18030352.